News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,915 Results
Type
Article (14314)
Company Profile (282)
Press Release (254319)
Section
Business (80483)
Career Advice (154)
Deals (13331)
Drug Delivery (35)
Drug Development (50553)
Employer Resources (31)
FDA (5793)
Job Trends (5238)
News (145815)
Policy (10250)
Tag
Academia (922)
Alliances (21868)
Alzheimer's disease (803)
Antibody-drug conjugate (ADC) (78)
Approvals (5798)
Artificial intelligence (99)
Bankruptcy (107)
Best Places to Work (4667)
Biotechnology (232)
Breast cancer (133)
Cancer (1151)
Cardiovascular disease (92)
Career advice (134)
CAR-T (100)
Cell therapy (288)
Clinical research (40714)
Collaboration (454)
Compensation (187)
COVID-19 (1047)
C-suite (122)
Cystic fibrosis (75)
Data (1186)
Diabetes (110)
Diagnostics (1332)
Earnings (29630)
Events (48184)
Executive appointments (371)
FDA (6321)
Funding (425)
Gene editing (79)
Gene therapy (208)
GLP-1 (341)
Government (1113)
Healthcare (6818)
Infectious disease (1100)
Inflammatory bowel disease (106)
IPO (7302)
Job creations (865)
Job search strategy (127)
Layoffs (200)
Legal (1459)
Lung cancer (164)
Manufacturing (107)
Medical device (2754)
Medtech (2755)
Mergers & acquisitions (6267)
Metabolic disorders (327)
Neuroscience (1128)
NextGen: Class of 2025 (2102)
Non-profit (963)
Northern California (1385)
Obesity (169)
Opinion (101)
Parkinson's disease (90)
Patents (93)
People (25731)
Phase I (14372)
Phase II (18930)
Phase III (11975)
Pipeline (550)
Postmarket research (856)
Preclinical (6027)
Radiopharmaceuticals (211)
Rare diseases (254)
Real estate (1433)
Regulatory (8584)
Research institute (948)
Series A (82)
Southern California (1235)
Startups (1978)
United States (10983)
Vaccines (195)
Weight loss (97)
Date
Today (17)
Last 7 days (478)
Last 30 days (1529)
Last 365 days (20440)
2025 (3148)
2024 (20662)
2023 (22602)
2022 (27053)
2021 (28073)
2020 (23848)
2019 (16684)
2018 (12109)
2017 (13920)
2016 (12041)
2015 (14488)
2014 (10508)
2013 (7555)
2012 (7622)
2011 (7732)
2010 (7523)
Location
Africa (150)
Asia (17231)
Australia (2919)
California (3171)
Canada (982)
China (283)
Colorado (120)
Connecticut (132)
Delaware (77)
Europe (37145)
Florida (370)
Georgia (93)
Illinois (211)
Indiana (76)
Maryland (410)
Massachusetts (2509)
Minnesota (125)
New Jersey (787)
New York (873)
North Carolina (486)
Northern California (1385)
Ohio (99)
Pennsylvania (599)
South America (226)
Southern California (1235)
Texas (352)
Washington State (296)
268,915 Results for "shield therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Cimeio Therapeutics Announces Publication in Nature Demonstrating That CD45 ADC and Shielded HSCs Represent a Potentially Universal Therapy for Blood Cancers
Cimeio Therapeutics today announced a publication in Nature showing that its CD45 antibody-drug conjugate (ADC) eradicated aggressive leukemic cells in vivo, while hematopoiesis was fully preserved and protected from the ADC via shielded hematopoietic stem cells (HSCs).
May 22, 2024
·
3 min read
Press Releases
Guardant Health’s Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program
January 30, 2025
·
4 min read
Business
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
Teva Pharmaceutical Industries Ltd. today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the Company’s manufacturing and supply division, effective June 3, 2024.
May 15, 2024
·
7 min read
Press Releases
Radiation Shield Technologies Demron Shields High Energy Beta Radiation by 91%
August 20, 2024
·
2 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Genetown
Cimeio Therapeutics Presents Data for its CD52 Shielding Variant at ASGCT
Cimeio Therapeutics is presenting data for its CD52 program during this week’s Annual Meeting of the American Society of Cell & Gene Therapy (ASGCT) in Baltimore.
May 9, 2024
·
2 min read
Press Releases
PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients with a Concurrent Private Placement of up to $41 Million
December 24, 2024
·
9 min read
BioMidwest
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
NeurAxis, Inc., a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced receipt of Blue Cross and Blue Shield of Kansas City policy coverage for approximately one million lives.
March 4, 2024
·
3 min read
Press Releases
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
December 10, 2024
·
5 min read
Biotech Bay
Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from two real-world studies at the 2024 Digestive Disease Week (DDW) meeting in Washington, DC, highlighting the value of the company’s Shield™ test in colorectal cancer (CRC) screening.
May 16, 2024
·
3 min read
1 of 26,892
Next
